STOCK TITAN

Tuniu Financials

TOUR
FY2025 annual
Revenue $82.6M +17.5% YoY
Net Income $4.5M -57.9% YoY
EPS (Diluted) $0.01 -66.7% YoY
Free Cash Flow -$16.6M -243.6% YoY
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

Tuniu (TOUR) reported $82.6M in revenue for fiscal year 2025, up 17.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TOUR FY2025

FY2025 exposed a cash-conversion break: higher sales arrived with thinner margins and a much smaller cash cushion.

In FY2025, operating cash flow swung from $13.2M to -$15.6M even though net income stayed positive. At the same time, gross margin fell from 69.7% to 58.0%, suggesting the extra volume came from less profitable activity and absorbed cash rather than releasing it.

Cash fell to $29.6M from $63.7M. Yet the current ratio improved to 2.0x, and total liabilities were lower than FY2024, so the weaker cash balance looks tied more to balance-sheet cleanup than to new borrowing pressure. That matters because short-term solvency actually improved.

The company still kept SG&A discipline, which helped preserve a small operating profit after margins compressed. But buybacks and dividends distributed $11.6M in FY2025, so shareholder returns magnified a year when the core business did not fund itself. That is a notable shift from FY2024, when operations did produce cash on their own.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 48 / 100
Financial Health Score 48/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Tuniu's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
56
Dilution
79
R&D Intensity
37
Revenue Progress
67
Burn Trend
0

Not available for Tuniu, and counted as zero in the overall score.

Balance Sheet
48
Altman Z-Score Distress
-6.05

Tuniu scores -6.05, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($53.2M) relative to total liabilities ($91.8M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Tuniu passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

For every $1 of reported earnings, Tuniu used $3.50 of operating cash (-$15.6M OCF vs $4.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Interest Coverage Safe
5.56x

Tuniu earns $5.56 in operating income for every $1 of interest expense ($1.6M vs $289K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$82.6M
YoY+17.5%
5Y CAGR+3.7%
10Y CAGR-23.3%

Tuniu generated $82.6M in revenue in fiscal year 2025. This represents an increase of 17.5% from the prior year.

EBITDA
$2.3M
YoY-75.6%

Tuniu's EBITDA was $2.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 75.6% from the prior year.

Net Income
$4.5M
YoY-57.9%

Tuniu reported $4.5M in net income in fiscal year 2025. This represents a decrease of 57.9% from the prior year.

EPS (Diluted)
$0.01
YoY-66.7%

Tuniu earned $0.01 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 66.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
-$16.6M
YoY-243.6%

Tuniu recorded an outflow of $16.6M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 243.6% from the prior year.

Cash & Debt
$29.6M
YoY-53.5%
5Y CAGR-2.0%
10Y CAGR-20.7%

Tuniu held $29.6M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
328M
YoY-6.7%
5Y CAGR-3.4%
10Y CAGR+1.3%

Tuniu had 328M shares outstanding in fiscal year 2025. This represents a decrease of 6.7% from the prior year.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
58.0%
YoY-11.8pp
5Y CAGR+10.6pp
10Y CAGR+53.1pp

Tuniu's gross margin was 58.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 11.8 percentage points from the prior year.

Operating Margin
1.9%
YoY-10.4pp
10Y CAGR+21.0pp

Tuniu's operating margin was 1.9% in fiscal year 2025, reflecting core business profitability. This is down 10.4 percentage points from the prior year.

Net Margin
5.4%
YoY-9.6pp
10Y CAGR+24.5pp

Tuniu's net profit margin was 5.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 9.6 percentage points from the prior year.

Return on Equity
3.0%
YoY-4.1pp
5Y CAGR+97.5pp
10Y CAGR+47.0pp

Tuniu's ROE was 3.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.1 percentage points from the prior year.

Capital Allocation

R&D Spending
$8.4M
YoY+16.9%
5Y CAGR-11.3%
10Y CAGR-15.6%

Tuniu invested $8.4M in research and development in fiscal year 2025. This represents an increase of 16.9% from the prior year.

Share Buybacks
$7.3M
YoY+19.1%

Tuniu spent $7.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 19.1% from the prior year.

Capital Expenditures
$1.0M
YoY-37.1%
5Y CAGR-25.2%
10Y CAGR-27.1%

Tuniu invested $1.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 37.1% from the prior year.

TOUR Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TOUR annual income statement
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14
Revenue$82.6M+17.5%$70.4M+13.2%$62.2M+133.4%$26.6M-60.2%$66.9M-3.0%$69.0M-78.9%$327.6M+0.6%$325.8M-3.3%$336.9M-77.8%$1.5B+28.7%$1.2B+107.2%$569.7M
Cost of Revenue$34.7M+63.0%$21.3M+2.5%$20.8M+52.4%$13.6M-65.9%$40.0M+10.1%$36.3M-78.9%$172.4M+11.3%$154.9MN/AN/AN/AN/A
Gross Profit$47.9M-2.3%$49.0M+18.6%$41.4M+218.6%$13.0M-51.8%$26.9M-17.6%$32.7M-79.0%$155.3M-9.2%$170.9M-4.8%$179.5M+98.8%$90.3M+57.8%$57.2M+57.0%$36.4M
R&D Expenses$8.4M+16.9%$7.2M-10.1%$8.0M+9.0%$7.4M-14.1%$8.6M-44.4%$15.4M-64.7%$43.6M-4.9%$45.8M-44.9%$83.2M-4.0%$86.6M+88.2%$46.0M+172.3%$16.9M
SG&A Expenses$10.3M-14.4%$12.0M-24.7%$15.9M+1.0%$15.8M-42.2%$27.3M-83.9%$170.0M+57.9%$107.6M+51.9%$70.9M-27.7%$98.0M+3.3%$94.9M+59.5%$59.5M+121.1%$26.9M
Operating Income$1.6M-81.5%$8.7M+160.4%-$14.3M+52.9%-$30.5M-7.0%-$28.5M+86.1%-$205.5M-64.3%-$125.1M-146.4%-$50.8M+62.6%-$135.8M+62.6%-$362.9M-61.5%-$224.6M-194.6%-$76.2M
Interest Expense$289K-36.5%$455K-8.3%$496K-30.3%$712K-39.5%$1.2M-76.2%$4.9M+1.1%$4.9MN/AN/AN/AN/AN/A
Income Tax$204K+77.4%$115K-43.3%$203K+291.5%-$106K-630.0%$20K+102.0%-$1.0M-848.5%$136K+518.2%$22K-99.1%$2.4M+1076.4%-$246K-170.3%-$91KN/A
Net Income$4.5M-57.9%$10.6M+175.6%-$14.0M+50.1%-$28.0M-47.0%-$19.1M+90.5%-$200.5M-100.9%-$99.8M-269.8%-$27.0M+77.1%-$117.9M+66.3%-$349.6M-55.2%-$225.3M-212.1%-$72.2M
EPS (Diluted)$0.01-66.7%$0.03+175.0%-$0.04+50.0%-$0.08-60.0%-$0.05N/AN/AN/AN/AN/AN/AN/A

TOUR Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TOUR annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14
Total Assets$228.8M-12.5%$261.6M-5.3%$276.1M+1.4%$272.3M-24.5%$360.6M-26.4%$489.9M-48.3%$947.5M-0.6%$953.7M-6.8%$1.0B-22.4%$1.3B+18.9%$1.1B+160.2%$426.3M
Current Assets$185.4M+12.5%$164.9M-22.4%$212.4M+22.1%$174.0M-24.9%$231.5M-33.9%$350.1M-36.2%$549.2M-14.3%$641.1M-18.0%$782.2M-27.6%$1.1B+26.4%$855.1M+107.7%$411.7M
Cash & Equivalents$29.6M-53.5%$63.7M+19.3%$53.4M+139.3%$22.3M-59.3%$54.8M+67.4%$32.7M-22.9%$42.4M-47.9%$81.5M+9.5%$74.4M-55.4%$166.8M-44.9%$302.6M+1108.9%$25.0M
Accounts Receivable$9.6M+61.1%$5.9M+1.2%$5.9M+20.2%$4.9M-72.2%$17.6M-56.6%$40.5M-46.8%$76.1M+50.6%$50.5M+14.7%$44.1M+38.8%$31.7M+81.5%$17.5M+1154.8%$1.4M
GoodwillN/AN/A$0-100.0%$16.1M-52.0%$33.6M-7.6%$36.4M+2.4%$35.6M+55.3%$22.9M+6.6%$21.5M-5.4%$22.7M+15.4%$19.7MN/A
Total Liabilities$91.8M-25.6%$123.4M-10.7%$138.1M+16.2%$118.8M-27.5%$163.9M-41.2%$278.8M-49.5%$552.7M+20.9%$457.1M+0.4%$455.5M-31.0%$660.2M+11.1%$594.1M+198.2%$199.3M
Current Liabilities$91.0M-25.7%$122.4M-9.3%$135.1M+20.3%$112.3M-26.9%$153.6M-42.5%$267.4M-50.3%$538.5M+19.3%$451.3M+0.5%$449.0M-31.2%$652.3M+11.5%$585.2M+199.1%$195.7M
Long-Term DebtN/AN/A$1.5M-15.6%$1.7M-23.0%$2.3M-34.9%$3.5M+148.6%$1.4MN/AN/AN/AN/AN/A
Total Equity$147.3M-0.5%$148.0M+2.0%$145.2M-9.6%$160.6M-19.3%$199.2M-6.2%$212.2M-45.5%$389.4M-20.1%$487.3M-11.8%$552.6M-14.4%$645.5M+25.9%$512.7M+125.8%$227.0M
Retained Earnings-$1.2B-7.8%-$1.1B+3.7%-$1.1B+1.7%-$1.2B+5.3%-$1.2B-4.0%-$1.2B-28.9%-$917.3M-10.8%-$827.8M+2.2%-$846.2M-23.6%-$684.9M-90.6%-$359.4M-156.6%-$140.1M

Not reported in any period shown, so not listed: Inventory.

TOUR Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TOUR annual cash flow statement
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14
Operating Cash Flow-$15.6M-218.3%$13.2M-59.8%$32.8M+258.2%-$20.7M+41.6%-$35.5M+82.4%-$201.2M-1063.1%-$17.3M-144.4%$39.0M+160.6%-$64.3M+80.1%-$322.6M-305.9%-$79.5M-81.9%-$43.7M
Capital Expenditures$1.0M-37.1%$1.6M+17.3%$1.4M+47.5%$935K-59.6%$2.3M-46.7%$4.3M-75.3%$17.6M+1.3%$17.4M-29.6%$24.7M+45.3%$17.0M-29.3%$24.0M+194.2%$8.2M
Free Cash Flow-$16.6M-243.6%$11.6M-63.2%$31.4M+245.0%-$21.7M+42.7%-$37.8M+81.6%-$205.6M-489.1%-$34.9M-261.4%$21.6M+124.3%-$89.0M+73.8%-$339.5M-228.2%-$103.5M-99.5%-$51.9M
Investing Cash Flow$698K-80.9%$3.7M-36.6%$5.8M+176.7%-$7.5M-106.8%$110.4M-37.8%$177.6M+313.9%-$83.0M-470.8%$22.4M-77.5%$99.6MN/AN/AN/A
Financing Cash Flow-$22.9M-125.9%-$10.1M-218.6%-$3.2M-4444.3%-$70K+99.9%-$54.1M-68.4%-$32.1M-146.1%$69.7M+429.9%-$21.1M+82.5%-$120.6MN/AN/A$248.3M
Dividends Paid$4.3MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Share Buybacks$7.3M+19.1%$6.2MN/AN/AN/A$47K-97.6%$1.9M-90.4%$20.2M-20.8%$25.5M+799.5%$2.8MN/AN/A

TOUR Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

TOUR annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14
Gross Margin58.0%-11.8pp69.7%+3.2pp66.6%+17.8pp48.8%+8.5pp40.2%-7.1pp47.3%0.0pp47.4%-5.1pp52.5%-0.8pp53.3%+47.3pp5.9%+1.1pp4.9%-1.6pp6.4%
Operating Margin1.9%-10.4pp12.3%+35.4pp-23.1%-114.5%-42.6%-297.8%-38.2%-22.6pp-15.6%+24.7pp-40.3%-16.4pp-23.9%-4.9pp-19.0%-5.6pp-13.4%
Net Margin5.4%-9.6pp15.0%+37.5pp-22.5%-105.3%-28.5%-290.5%-30.4%-22.2pp-8.3%+26.7pp-35.0%-12.0pp-23.0%-3.9pp-19.1%-6.4pp-12.7%
Return on Equity3.0%-4.1pp7.1%+16.8pp-9.6%+7.8pp-17.4%-7.9pp-9.6%+84.9pp-94.5%-68.8pp-25.6%-20.1pp-5.5%+15.8pp-21.3%+32.8pp-54.1%-10.2pp-43.9%-12.2pp-31.8%
Return on Assets1.9%-2.1pp4.0%+9.1pp-5.1%+5.2pp-10.3%-5.0pp-5.3%+35.6pp-40.9%-30.4pp-10.5%-7.7pp-2.8%+8.7pp-11.5%+15.0pp-26.5%-6.2pp-20.3%-3.4pp-16.9%
Current Ratio2.04+0.7x1.35-0.2x1.570.0x1.550.0x1.51+0.2x1.31+0.3x1.02-0.4x1.42-0.3x1.74+0.1x1.66+0.2x1.46-0.6x2.10
Debt-to-Equity0.62-0.2x0.83+0.8x0.010.0x0.010.0x0.010.0x0.020.0x0.00-0.9x0.94+0.1x0.82-0.2x1.02-0.1x1.16+0.3x0.88
FCF Margin-20.1%-36.5pp16.4%-34.1pp50.5%+131.9pp-81.4%-24.8pp-56.5%-297.9%-10.7%-17.3pp6.6%+33.1pp-26.4%-4.1pp-22.4%-13.6pp-8.8%+0.3pp-9.1%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is Tuniu's annual revenue?

Tuniu (TOUR) reported $82.6M in total revenue for fiscal year 2025. This represents a 17.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Tuniu's revenue growing?

Tuniu (TOUR) revenue grew by 17.5% year-over-year, from $70.4M to $82.6M in fiscal year 2025.

Is Tuniu profitable?

Yes, Tuniu (TOUR) reported a net income of $4.5M in fiscal year 2025, with a net profit margin of 5.4%.

Tuniu (TOUR) reported diluted earnings per share of $0.01 for fiscal year 2025. This represents a -66.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Tuniu (TOUR) had EBITDA of $2.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Tuniu (TOUR) had a gross margin of 58.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Tuniu (TOUR) had an operating margin of 1.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Tuniu (TOUR) had a net profit margin of 5.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Tuniu (TOUR) has a return on equity of 3.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Tuniu (TOUR) recorded an outflow of $16.6M in free cash flow during fiscal year 2025. This represents a -243.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Tuniu (TOUR) recorded an outflow of $15.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Tuniu (TOUR) had $228.8M in total assets as of fiscal year 2025, including both current and long-term assets.

Tuniu (TOUR) invested $1.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Tuniu (TOUR) invested $8.4M in research and development during fiscal year 2025.

Yes, Tuniu (TOUR) spent $7.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Tuniu (TOUR) had 328M shares outstanding as of fiscal year 2025.

Tuniu (TOUR) had a current ratio of 2.04 as of fiscal year 2025, which is generally considered healthy.

Tuniu (TOUR) had a debt-to-equity ratio of 0.62 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Tuniu (TOUR) had a return on assets of 1.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Tuniu (TOUR) had $29.6M in cash against an annual operating cash burn of $15.6M. This gives an estimated cash runway of approximately 23 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Tuniu (TOUR) has an Altman Z-Score of -6.05, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Tuniu (TOUR) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

For every $1 of reported earnings, Tuniu (TOUR) used $3.50 of operating cash (-$15.6M OCF vs $4.5M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Tuniu (TOUR) has an interest coverage ratio of 5.56x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Tuniu (TOUR) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top